The field of vascular anomalies is advancing rapidly with the introduction of novel pharmacotherapy and the identification of mutations responsible for several types of vascular malformation syndromes.

Historically, the field has been handicapped because it is confusing; many anomalies look similar, and imprecise terminology has been used to describe different types of lesions.

Photo courtesy of Arin K. Greene, M.D., FACS, FAAP

Confusion about vascular anomalies continues because many lesions look similar and imprecise terminology often is used, leading to incorrect treatment. Because of these complexities and rapidly evolving new treatments, additional education about the field is necessary.

Unfortunately, confusion continues to pervade the medical community. In a recent literature review, 71% of published articles used the term “hemangioma” to describe another type of vascular anomaly, and 20% of patients whose lesion was labeled erroneously received incorrect treatment (
, et al
Plast Reconstr Surg

You do not currently have access to this content.